Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900016 · ClinicalTrials.gov registry record
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
A clinical trial, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 37
- Enrollment target
NCT00900016 is a clinical trial that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 37 participants.
The verdict
NCT00900016 has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is assessing fibroblast activity in patients with localized pancreatic cancer undergoing surgery.
Interventions
- GENETIC protein expression analysis
- OTHER laboratory biomarker analysis
- OTHER immunohistochemistry staining method
- GENETIC western blotting
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-08 |
| Est. Completion | 2017-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900016
The ClinicalTrials.gov registry entry for NCT00900016 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which protein expression analysis is the first listed.
NCT00900016 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900016 about?
NCT00900016 is a clinical study titled "Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is assessing fibroblast activity in patients with localized pancreati...
What is the current status of trial NCT00900016?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2007-08. Estimated completion is 2017-06-23.
What interventions are being tested in trial NCT00900016?
The interventions under investigation include: protein expression analysis (GENETIC), laboratory biomarker analysis (OTHER), immunohistochemistry staining method (OTHER), western blotting (GENETIC), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00900016?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.